Theralink Technologies named commercial provider of its patented Reverse Phase Protein Array (RPPA) technology for breast cancer patients

Press/Media

Period23 Feb 2021

Media coverage

1

Media coverage

  • TitleTheralink Technologies named commercial provider of its patented Reverse Phase Protein Array (RPPA) technology for breast cancer patients
    Media name/outletImpact Financial News
    Country/TerritoryUnited Kingdom
    Date23/02/21
    PersonsEmmanuel Petricoin